![](https://endpts.com/wp-content/uploads/2024/01/Julie-Wu-Full-Life-1-scaled.jpg)
Julie Wu, Full-Life Technologies CFO
Trailing Novartis and Eli Lilly, radiopharmaceuticals startup Full-Life Technologies nabs $63M to test new PSMA drug
As the US radiopharmaceutical space heats up with the acquisitions of RayzeBio and Point Biopharma, a younger startup based …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.